MedTrace Logo

Cannabis Abstinence and Neurocognitive Assessment in Adolescence

NCT07160153 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2025-09-19

No results posted yet for this study

Summary

Cannabis Abstinence and Neurocognitive Assessment in Adolescence

Conditions

  • Cannabis Dependence
  • Harmful Use
  • Cognitive Assessment

Interventions

DIAGNOSTIC_TEST

Neurocognitive assessment

Neurocognitive battery: TMT-Trail Making Test Auditory Verbal Learning Test Stroop Test Tower of London (ToL), Shallice version Continuous Performance Test-Identical Pairs Other psychometrics: The level of dependence is quantified using the CAST (Cannabis Abuse Screening Test)

DIAGNOSTIC_TEST

Urine toxicological assessment

Urine toxicological assessment

Sponsors & Collaborators

  • University Hospital Pilsen

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-03
Primary Completion
2028-12-31
Completion
2029-08-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07160153 on ClinicalTrials.gov